

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 9.95170324 |
| 2 | central nervous system myelination (GO:0022010) | 9.95170324 |
| 3 | fatty acid elongation (GO:0030497) | 8.93925190 |
| 4 | * cholesterol biosynthetic process (GO:0006695) | 7.90230154 |
| 5 | * sterol biosynthetic process (GO:0016126) | 6.94124910 |
| 6 | ensheathment of neurons (GO:0007272) | 6.09950198 |
| 7 | axon ensheathment (GO:0008366) | 6.09950198 |
| 8 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.07036183 |
| 9 | myelination (GO:0042552) | 6.06315087 |
| 10 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 5.42455633 |
| 11 | * isoprenoid biosynthetic process (GO:0008299) | 5.18788025 |
| 12 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.97804871 |
| 13 | establishment of mitochondrion localization (GO:0051654) | 4.87211386 |
| 14 | nucleobase catabolic process (GO:0046113) | 4.85069005 |
| 15 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.81527942 |
| 16 | myelin maintenance (GO:0043217) | 4.51765891 |
| 17 | negative regulation of neurotransmitter transport (GO:0051589) | 4.48737551 |
| 18 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.37305749 |
| 19 | regulation of collateral sprouting (GO:0048670) | 4.32878273 |
| 20 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.31074400 |
| 21 | response to methylmercury (GO:0051597) | 4.28655716 |
| 22 | apical protein localization (GO:0045176) | 4.21386265 |
| 23 | glycerophospholipid catabolic process (GO:0046475) | 4.14039533 |
| 24 | thioester biosynthetic process (GO:0035384) | 4.10962162 |
| 25 | acyl-CoA biosynthetic process (GO:0071616) | 4.10962162 |
| 26 | postsynaptic membrane organization (GO:0001941) | 4.02828978 |
| 27 | negative regulation of protein localization to cell surface (GO:2000009) | 4.02798969 |
| 28 | very long-chain fatty acid metabolic process (GO:0000038) | 3.97400200 |
| 29 | substantia nigra development (GO:0021762) | 3.96530104 |
| 30 | oligodendrocyte differentiation (GO:0048709) | 3.87713323 |
| 31 | asymmetric protein localization (GO:0008105) | 3.86021559 |
| 32 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.75916578 |
| 33 | layer formation in cerebral cortex (GO:0021819) | 3.75592197 |
| 34 | photoreceptor cell differentiation (GO:0046530) | 3.65873592 |
| 35 | eye photoreceptor cell differentiation (GO:0001754) | 3.65873592 |
| 36 | presynaptic membrane organization (GO:0097090) | 3.57228578 |
| 37 | olfactory bulb development (GO:0021772) | 3.57088945 |
| 38 | amyloid precursor protein metabolic process (GO:0042982) | 3.48751978 |
| 39 | L-amino acid import (GO:0043092) | 3.48316196 |
| 40 | creatine metabolic process (GO:0006600) | 3.45381700 |
| 41 | regulation of development, heterochronic (GO:0040034) | 3.40092930 |
| 42 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.40068957 |
| 43 | presynaptic membrane assembly (GO:0097105) | 3.37704040 |
| 44 | negative regulation of astrocyte differentiation (GO:0048712) | 3.37701681 |
| 45 | limb bud formation (GO:0060174) | 3.37279903 |
| 46 | peripheral nervous system axon ensheathment (GO:0032292) | 3.34529147 |
| 47 | myelination in peripheral nervous system (GO:0022011) | 3.34529147 |
| 48 | astrocyte development (GO:0014002) | 3.34318335 |
| 49 | neuron cell-cell adhesion (GO:0007158) | 3.31112475 |
| 50 | regulation of lipoprotein metabolic process (GO:0050746) | 3.30363756 |
| 51 | response to redox state (GO:0051775) | 3.24550727 |
| 52 | L-serine metabolic process (GO:0006563) | 3.23820261 |
| 53 | * alcohol biosynthetic process (GO:0046165) | 3.17220686 |
| 54 | * cholesterol metabolic process (GO:0008203) | 3.16936239 |
| 55 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.15717034 |
| 56 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.15717034 |
| 57 | negative regulation of axonogenesis (GO:0050771) | 3.15124537 |
| 58 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.12504085 |
| 59 | thioester metabolic process (GO:0035383) | 3.05834621 |
| 60 | acyl-CoA metabolic process (GO:0006637) | 3.05834621 |
| 61 | axon development (GO:0061564) | 3.05275027 |
| 62 | regulation of timing of cell differentiation (GO:0048505) | 3.01458471 |
| 63 | import into cell (GO:0098657) | 3.00871373 |
| 64 | spinal cord development (GO:0021510) | 2.99404963 |
| 65 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.98048981 |
| 66 | serine family amino acid catabolic process (GO:0009071) | 2.97569323 |
| 67 | * steroid biosynthetic process (GO:0006694) | 2.97225467 |
| 68 | acetyl-CoA metabolic process (GO:0006084) | 2.96349379 |
| 69 | neuron remodeling (GO:0016322) | 2.95339851 |
| 70 | retinal ganglion cell axon guidance (GO:0031290) | 2.93349516 |
| 71 | * sterol metabolic process (GO:0016125) | 2.88997212 |
| 72 | DNA double-strand break processing (GO:0000729) | 2.88419538 |
| 73 | dendritic spine morphogenesis (GO:0060997) | 2.88000430 |
| 74 | negative regulation of axon extension (GO:0030517) | 2.86784972 |
| 75 | negative regulation of glial cell differentiation (GO:0045686) | 2.86095617 |
| 76 | nonmotile primary cilium assembly (GO:0035058) | 2.83878966 |
| 77 | positive regulation of actin filament depolymerization (GO:0030836) | 2.83168731 |
| 78 | peripheral nervous system development (GO:0007422) | 2.81887961 |
| 79 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.81798698 |
| 80 | vocalization behavior (GO:0071625) | 2.81595953 |
| 81 | protein neddylation (GO:0045116) | 2.80852255 |
| 82 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.78791155 |
| 83 | forebrain neuron differentiation (GO:0021879) | 2.78036885 |
| 84 | mechanosensory behavior (GO:0007638) | 2.76171773 |
| 85 | triglyceride biosynthetic process (GO:0019432) | 2.75106140 |
| 86 | magnesium ion transport (GO:0015693) | 2.73552454 |
| 87 | mitochondrion transport along microtubule (GO:0047497) | 2.73538999 |
| 88 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.73538999 |
| 89 | neural nucleus development (GO:0048857) | 2.73199242 |
| 90 | auditory behavior (GO:0031223) | 2.72982088 |
| 91 | protein palmitoylation (GO:0018345) | 2.71967428 |
| 92 | nucleotide transmembrane transport (GO:1901679) | 2.71677279 |
| 93 | estrogen biosynthetic process (GO:0006703) | 2.70740754 |
| 94 | lateral sprouting from an epithelium (GO:0060601) | 2.70037596 |
| 95 | amyloid precursor protein catabolic process (GO:0042987) | 2.69701452 |
| 96 | neuron recognition (GO:0008038) | 2.68395964 |
| 97 | dorsal/ventral axis specification (GO:0009950) | 2.66781351 |
| 98 | L-phenylalanine catabolic process (GO:0006559) | 2.66343312 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.66343312 |
| 100 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.62488176 |
| 101 | acylglycerol biosynthetic process (GO:0046463) | 2.61457213 |
| 102 | neutral lipid biosynthetic process (GO:0046460) | 2.61457213 |
| 103 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.60994156 |
| 104 | central nervous system neuron axonogenesis (GO:0021955) | 2.60806280 |
| 105 | transmission of nerve impulse (GO:0019226) | 2.60517898 |
| 106 | iron coordination entity transport (GO:1901678) | 2.60271059 |
| 107 | amino acid import (GO:0043090) | 2.59876248 |
| 108 | neuronal stem cell maintenance (GO:0097150) | 2.58048344 |
| 109 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.57295055 |
| 110 | detection of temperature stimulus (GO:0016048) | 2.56719642 |
| 111 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.56547015 |
| 112 | membrane tubulation (GO:0097320) | 2.55458556 |
| 113 | cerebral cortex cell migration (GO:0021795) | 2.54747227 |
| 114 | nerve growth factor signaling pathway (GO:0038180) | 2.54552092 |
| 115 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.54039504 |
| 116 | glycosylceramide metabolic process (GO:0006677) | 2.52830049 |
| 117 | somite development (GO:0061053) | 2.52161272 |
| 118 | glial cell differentiation (GO:0010001) | 2.51671746 |
| 119 | response to phenylpropanoid (GO:0080184) | 2.50564368 |
| 120 | peptidyl-cysteine modification (GO:0018198) | 2.50468831 |
| 121 | axonal fasciculation (GO:0007413) | 2.49339024 |
| 122 | heme transport (GO:0015886) | 2.49032183 |
| 123 | C4-dicarboxylate transport (GO:0015740) | 2.46131837 |
| 124 | enteric nervous system development (GO:0048484) | 2.45627444 |
| 125 | positive regulation of neurological system process (GO:0031646) | 2.45088262 |
| 126 | adult walking behavior (GO:0007628) | 2.43949504 |
| 127 | neurotransmitter uptake (GO:0001504) | 2.43499377 |
| 128 | alpha-linolenic acid metabolic process (GO:0036109) | 2.41051796 |
| 129 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.40561133 |
| 130 | terpenoid biosynthetic process (GO:0016114) | 2.40055697 |
| 131 | fatty acid biosynthetic process (GO:0006633) | 2.39887139 |
| 132 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.39516429 |
| 133 | mitotic sister chromatid cohesion (GO:0007064) | 2.39312539 |
| 134 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.36876522 |
| 135 | positive regulation of synapse assembly (GO:0051965) | 2.36626497 |
| 136 | intraciliary transport (GO:0042073) | 2.35242356 |
| 137 | response to auditory stimulus (GO:0010996) | 2.34562353 |
| 138 | gastrulation with mouth forming second (GO:0001702) | 2.33476535 |
| 139 | DNA damage response, detection of DNA damage (GO:0042769) | 2.32792471 |
| 140 | axon extension (GO:0048675) | 2.30992815 |
| 141 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.30903735 |
| 142 | dendrite morphogenesis (GO:0048813) | 2.30649346 |
| 143 | cell proliferation in forebrain (GO:0021846) | 2.28048386 |
| 144 | regulation of growth hormone secretion (GO:0060123) | 2.27977858 |
| 145 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.26469898 |
| 146 | DNA topological change (GO:0006265) | 2.26408164 |
| 147 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.24999143 |
| 148 | synapse assembly (GO:0007416) | 2.24919928 |
| 149 | serine family amino acid metabolic process (GO:0009069) | 2.23057894 |
| 150 | hindbrain development (GO:0030902) | 2.22411879 |
| 151 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.22355076 |
| 152 | generation of neurons (GO:0048699) | 2.21953026 |
| 153 | neuron migration (GO:0001764) | 2.21561820 |
| 154 | ephrin receptor signaling pathway (GO:0048013) | 2.20032535 |
| 155 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.18869450 |
| 156 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.18539899 |
| 157 | establishment of nucleus localization (GO:0040023) | 2.18248820 |
| 158 | lens morphogenesis in camera-type eye (GO:0002089) | 2.18219052 |
| 159 | protein localization to synapse (GO:0035418) | 2.15975304 |
| 160 | acrosome assembly (GO:0001675) | 2.15546762 |
| 161 | hippocampus development (GO:0021766) | 2.15124842 |
| 162 | chromatin remodeling at centromere (GO:0031055) | 2.14450875 |
| 163 | cysteine metabolic process (GO:0006534) | 2.13774055 |
| 164 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.13704771 |
| 165 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.13656834 |
| 166 | ectodermal placode formation (GO:0060788) | 2.13486623 |
| 167 | * cellular response to cholesterol (GO:0071397) | 2.13306212 |
| 168 | serine family amino acid biosynthetic process (GO:0009070) | 2.12908774 |
| 169 | atrial cardiac muscle cell action potential (GO:0086014) | 2.12870577 |
| 170 | negative regulation of mRNA processing (GO:0050686) | 2.10103860 |
| 171 | glycine metabolic process (GO:0006544) | 2.07827122 |
| 172 | negative regulation of gliogenesis (GO:0014014) | 2.07511114 |
| 173 | neural tube formation (GO:0001841) | 2.07204574 |
| 174 | negative regulation of axon guidance (GO:1902668) | 2.06472584 |
| 175 | cerebral cortex neuron differentiation (GO:0021895) | 2.05545203 |
| 176 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.04917022 |
| 177 | cerebral cortex development (GO:0021987) | 2.03775004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.58243360 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.57266729 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.21290570 |
| 4 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.66885708 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.64709709 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.46098167 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.43908369 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.34971214 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.33746709 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.33415519 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.27565003 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.27233838 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21224699 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18719883 |
| 15 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.15175092 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.07135049 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.03332535 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.03332535 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.02678844 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.97293121 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.96093831 |
| 22 | EWS_26573619_Chip-Seq_HEK293_Human | 1.94358962 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.93874064 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92874003 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91450466 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.88246646 |
| 27 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.86567008 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.84898890 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.83299894 |
| 30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.81935972 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77473639 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77303736 |
| 33 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.73302813 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73230631 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71160115 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69770659 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.69645131 |
| 38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.66523950 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65626874 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.65516938 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.64710395 |
| 42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.63779901 |
| 43 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.63497053 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62699509 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62669623 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58384751 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.56581313 |
| 48 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.55225474 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54274194 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52443862 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51456217 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50434656 |
| 53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.50178072 |
| 54 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.48688799 |
| 55 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.47007527 |
| 56 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.46835248 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44722887 |
| 58 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44246522 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.44130024 |
| 60 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.42041429 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41434644 |
| 62 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.40785814 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37898925 |
| 64 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.37060114 |
| 65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35801236 |
| 66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.33566847 |
| 67 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33566847 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32579662 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32579662 |
| 70 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.31702676 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28504099 |
| 72 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27218708 |
| 73 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24940583 |
| 74 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.24529607 |
| 75 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.23768084 |
| 76 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.22207784 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21801675 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21786652 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21749638 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20891882 |
| 81 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20070585 |
| 82 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.16837546 |
| 83 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15684778 |
| 84 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.14834931 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14780608 |
| 86 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13399368 |
| 87 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.12396853 |
| 88 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.12151327 |
| 89 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11562397 |
| 90 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11562352 |
| 91 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11249596 |
| 92 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11144776 |
| 93 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09947521 |
| 94 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.08943211 |
| 95 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08932014 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08930796 |
| 97 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.08712156 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08307316 |
| 99 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08283949 |
| 100 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08195188 |
| 101 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.08017954 |
| 102 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.07681170 |
| 103 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07117019 |
| 104 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07117019 |
| 105 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.06520858 |
| 106 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05463011 |
| 107 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05358091 |
| 108 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04225327 |
| 109 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03816173 |
| 110 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03763079 |
| 111 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03573275 |
| 112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02656557 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02329190 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02025759 |
| 115 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02023110 |
| 116 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01715758 |
| 117 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01205379 |
| 118 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01101387 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00940850 |
| 120 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.00788356 |
| 121 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.00716161 |
| 122 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00533322 |
| 123 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00045096 |
| 124 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99314563 |
| 125 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98704175 |
| 126 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.98292915 |
| 127 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.97815790 |
| 128 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96617091 |
| 129 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96605371 |
| 130 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96460050 |
| 131 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.96404159 |
| 132 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.96025091 |
| 133 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.95978270 |
| 134 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.95880889 |
| 135 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95263684 |
| 136 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94861561 |
| 137 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94329292 |
| 138 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93761682 |
| 139 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93422288 |
| 140 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92853834 |
| 141 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92772680 |
| 142 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91975626 |
| 143 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.90876476 |
| 144 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90769946 |
| 145 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90533683 |
| 146 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90310902 |
| 147 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.90287423 |
| 148 | JUN_21703547_ChIP-Seq_K562_Human | 0.89810034 |
| 149 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89325298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.76265975 |
| 2 | MP0003880_abnormal_central_pattern | 3.57664934 |
| 3 | MP0004270_analgesia | 3.52209741 |
| 4 | MP0001529_abnormal_vocalization | 3.02939703 |
| 5 | MP0003122_maternal_imprinting | 3.01306859 |
| 6 | MP0003329_amyloid_beta_deposits | 2.90789077 |
| 7 | MP0000778_abnormal_nervous_system | 2.87517298 |
| 8 | MP0003690_abnormal_glial_cell | 2.70282945 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.55730664 |
| 10 | MP0004742_abnormal_vestibular_system | 2.42969669 |
| 11 | MP0004885_abnormal_endolymph | 2.34794078 |
| 12 | MP0001905_abnormal_dopamine_level | 2.34740781 |
| 13 | MP0003890_abnormal_embryonic-extraembry | 2.30032958 |
| 14 | MP0003121_genomic_imprinting | 2.28508595 |
| 15 | MP0005248_abnormal_Harderian_gland | 2.26011017 |
| 16 | MP0003634_abnormal_glial_cell | 2.25895537 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.23088966 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.21333456 |
| 19 | MP0001486_abnormal_startle_reflex | 2.18310054 |
| 20 | MP0003136_yellow_coat_color | 2.15197416 |
| 21 | MP0002272_abnormal_nervous_system | 2.14858693 |
| 22 | MP0004142_abnormal_muscle_tone | 2.10446570 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.04982051 |
| 24 | MP0005171_absent_coat_pigmentation | 1.99981768 |
| 25 | MP0004859_abnormal_synaptic_plasticity | 1.93470366 |
| 26 | MP0005423_abnormal_somatic_nervous | 1.88563336 |
| 27 | MP0003632_abnormal_nervous_system | 1.88380813 |
| 28 | MP0002064_seizures | 1.88065500 |
| 29 | MP0001485_abnormal_pinna_reflex | 1.85961216 |
| 30 | MP0001984_abnormal_olfaction | 1.80300620 |
| 31 | MP0001293_anophthalmia | 1.78723572 |
| 32 | MP0005394_taste/olfaction_phenotype | 1.71830627 |
| 33 | MP0005499_abnormal_olfactory_system | 1.71830627 |
| 34 | MP0005187_abnormal_penis_morphology | 1.70690968 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.69400785 |
| 36 | MP0004134_abnormal_chest_morphology | 1.66196478 |
| 37 | MP0008789_abnormal_olfactory_epithelium | 1.65861732 |
| 38 | MP0005451_abnormal_body_composition | 1.62819354 |
| 39 | MP0000955_abnormal_spinal_cord | 1.59032111 |
| 40 | MP0003119_abnormal_digestive_system | 1.54865149 |
| 41 | MP0005409_darkened_coat_color | 1.54546202 |
| 42 | MP0002229_neurodegeneration | 1.54451209 |
| 43 | MP0009745_abnormal_behavioral_response | 1.53436148 |
| 44 | MP0000462_abnormal_digestive_system | 1.53425982 |
| 45 | MP0000604_amyloidosis | 1.53007781 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.47909713 |
| 47 | MP0002139_abnormal_hepatobiliary_system | 1.43676880 |
| 48 | MP0003787_abnormal_imprinting | 1.42833324 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.42747188 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.42605917 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.42011128 |
| 52 | MP0003195_calcinosis | 1.40704272 |
| 53 | MP0003567_abnormal_fetal_cardiomyocyte | 1.40692653 |
| 54 | MP0010678_abnormal_skin_adnexa | 1.40074575 |
| 55 | MP0002733_abnormal_thermal_nociception | 1.39505186 |
| 56 | MP0002572_abnormal_emotion/affect_behav | 1.38587976 |
| 57 | MP0001968_abnormal_touch/_nociception | 1.38337720 |
| 58 | MP0001286_abnormal_eye_development | 1.38190060 |
| 59 | MP0002638_abnormal_pupillary_reflex | 1.38138321 |
| 60 | MP0002697_abnormal_eye_size | 1.37453207 |
| 61 | MP0001440_abnormal_grooming_behavior | 1.37034843 |
| 62 | MP0003631_nervous_system_phenotype | 1.35893753 |
| 63 | MP0009046_muscle_twitch | 1.35414742 |
| 64 | MP0006276_abnormal_autonomic_nervous | 1.35108765 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.34622568 |
| 66 | MP0003755_abnormal_palate_morphology | 1.34103086 |
| 67 | MP0001970_abnormal_pain_threshold | 1.33634952 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 1.29842274 |
| 69 | MP0005410_abnormal_fertilization | 1.29241917 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.28929887 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 1.27401628 |
| 72 | MP0001188_hyperpigmentation | 1.26064383 |
| 73 | MP0003385_abnormal_body_wall | 1.25956577 |
| 74 | MP0000647_abnormal_sebaceous_gland | 1.25745125 |
| 75 | MP0004924_abnormal_behavior | 1.24535827 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.24535827 |
| 77 | MP0002092_abnormal_eye_morphology | 1.24396081 |
| 78 | MP0001299_abnormal_eye_distance/ | 1.24032138 |
| 79 | MP0002067_abnormal_sensory_capabilities | 1.23233006 |
| 80 | MP0005391_vision/eye_phenotype | 1.21815603 |
| 81 | MP0008932_abnormal_embryonic_tissue | 1.21758967 |
| 82 | MP0002066_abnormal_motor_capabilities/c | 1.21647355 |
| 83 | MP0000049_abnormal_middle_ear | 1.21430273 |
| 84 | MP0004133_heterotaxia | 1.19766648 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 1.17706140 |
| 86 | MP0002752_abnormal_somatic_nervous | 1.17564385 |
| 87 | MP0002736_abnormal_nociception_after | 1.16518075 |
| 88 | MP0001177_atelectasis | 1.15979335 |
| 89 | MP0001963_abnormal_hearing_physiology | 1.15436156 |
| 90 | MP0002102_abnormal_ear_morphology | 1.14135543 |
| 91 | MP0002751_abnormal_autonomic_nervous | 1.14096177 |
| 92 | MP0003942_abnormal_urinary_system | 1.13584928 |
| 93 | MP0000383_abnormal_hair_follicle | 1.11578260 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 1.10957151 |
| 95 | MP0002282_abnormal_trachea_morphology | 1.09828120 |
| 96 | MP0009703_decreased_birth_body | 1.09679932 |
| 97 | MP0008058_abnormal_DNA_repair | 1.07423483 |
| 98 | MP0004043_abnormal_pH_regulation | 1.07388096 |
| 99 | MP0003011_delayed_dark_adaptation | 1.06986633 |
| 100 | MP0009053_abnormal_anal_canal | 1.06779385 |
| 101 | MP0002184_abnormal_innervation | 1.06632207 |
| 102 | MP0009672_abnormal_birth_weight | 1.06302261 |
| 103 | MP0003633_abnormal_nervous_system | 1.05854923 |
| 104 | MP0003315_abnormal_perineum_morphology | 1.05733970 |
| 105 | MP0002111_abnormal_tail_morphology | 1.04541591 |
| 106 | MP0005408_hypopigmentation | 1.01970120 |
| 107 | MP0005083_abnormal_biliary_tract | 1.01227814 |
| 108 | MP0008877_abnormal_DNA_methylation | 1.00139915 |
| 109 | MP0002152_abnormal_brain_morphology | 0.99694867 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.99550711 |
| 111 | MP0005195_abnormal_posterior_eye | 0.98942347 |
| 112 | MP0000762_abnormal_tongue_morphology | 0.98524230 |
| 113 | MP0003938_abnormal_ear_development | 0.98438477 |
| 114 | MP0000372_irregular_coat_pigmentation | 0.97377464 |
| 115 | MP0009250_abnormal_appendicular_skeleto | 0.95983119 |
| 116 | MP0003935_abnormal_craniofacial_develop | 0.95891381 |
| 117 | MP0002081_perinatal_lethality | 0.94975248 |
| 118 | MP0004858_abnormal_nervous_system | 0.94143265 |
| 119 | MP0004957_abnormal_blastocyst_morpholog | 0.94010948 |
| 120 | MP0002084_abnormal_developmental_patter | 0.93821246 |
| 121 | MP0004381_abnormal_hair_follicle | 0.92844794 |
| 122 | MP0000428_abnormal_craniofacial_morphol | 0.91745861 |
| 123 | MP0008569_lethality_at_weaning | 0.91041112 |
| 124 | MP0004197_abnormal_fetal_growth/weight/ | 0.90820984 |
| 125 | MP0003941_abnormal_skin_development | 0.88062171 |
| 126 | MP0003111_abnormal_nucleus_morphology | 0.87907173 |
| 127 | MP0003123_paternal_imprinting | 0.87743682 |
| 128 | MP0008438_abnormal_cutaneous_collagen | 0.86992241 |
| 129 | MP0005623_abnormal_meninges_morphology | 0.86584740 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.86496359 |
| 131 | MP0002085_abnormal_embryonic_tissue | 0.86205666 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.86115034 |
| 133 | MP0000516_abnormal_urinary_system | 0.86115034 |
| 134 | MP0000026_abnormal_inner_ear | 0.83826454 |
| 135 | MP0002557_abnormal_social/conspecific_i | 0.83813264 |
| 136 | MP0003718_maternal_effect | 0.82923272 |
| 137 | MP0000566_synostosis | 0.82820290 |
| 138 | MP0010030_abnormal_orbit_morphology | 0.82727657 |
| 139 | MP0002909_abnormal_adrenal_gland | 0.81302173 |
| 140 | MP0002822_catalepsy | 0.81188308 |
| 141 | MP0001346_abnormal_lacrimal_gland | 0.80549369 |
| 142 | MP0000747_muscle_weakness | 0.79166592 |
| 143 | MP0009780_abnormal_chondrocyte_physiolo | 0.78779947 |
| 144 | MP0004185_abnormal_adipocyte_glucose | 0.78749607 |
| 145 | MP0000579_abnormal_nail_morphology | 0.77918125 |
| 146 | MP0001340_abnormal_eyelid_morphology | 0.77712302 |
| 147 | MP0001661_extended_life_span | 0.75968433 |
| 148 | MP0003861_abnormal_nervous_system | 0.75903049 |
| 149 | MP0008260_abnormal_autophagy | 0.75713103 |
| 150 | MP0002090_abnormal_vision | 0.75459762 |
| 151 | MP0002938_white_spotting | 0.74088790 |
| 152 | MP0004811_abnormal_neuron_physiology | 0.73840868 |
| 153 | MP0000467_abnormal_esophagus_morphology | 0.70834824 |
| 154 | MP0005253_abnormal_eye_physiology | 0.70586657 |
| 155 | MP0000537_abnormal_urethra_morphology | 0.69624019 |
| 156 | MP0002233_abnormal_nose_morphology | 0.68986099 |
| 157 | MP0002118_abnormal_lipid_homeostasis | 0.66475923 |
| 158 | MP0001348_abnormal_lacrimal_gland | 0.65212924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.40058559 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.40058559 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.71170968 |
| 4 | Parakeratosis (HP:0001036) | 5.29839679 |
| 5 | Abnormality of the corticospinal tract (HP:0002492) | 5.27950182 |
| 6 | Abnormality of glycolysis (HP:0004366) | 4.77650550 |
| 7 | Increased serum pyruvate (HP:0003542) | 4.77650550 |
| 8 | Termporal pattern (HP:0011008) | 4.62317556 |
| 9 | Insidious onset (HP:0003587) | 4.62317556 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 4.40698277 |
| 11 | Sensory axonal neuropathy (HP:0003390) | 3.97377257 |
| 12 | Peripheral hypomyelination (HP:0007182) | 3.81965663 |
| 13 | Hepatoblastoma (HP:0002884) | 3.74207711 |
| 14 | Cortical dysplasia (HP:0002539) | 3.74139099 |
| 15 | Hypoplastic pelvis (HP:0008839) | 3.68494244 |
| 16 | Abnormality of the labia minora (HP:0012880) | 3.61557995 |
| 17 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.45772018 |
| 18 | Onion bulb formation (HP:0003383) | 3.45509023 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.41105175 |
| 20 | Spastic gait (HP:0002064) | 3.38174002 |
| 21 | Hyperglycinemia (HP:0002154) | 3.29184195 |
| 22 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.00123997 |
| 23 | Myokymia (HP:0002411) | 2.96410685 |
| 24 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.95344412 |
| 25 | Facial hemangioma (HP:0000329) | 2.91801152 |
| 26 | Akinesia (HP:0002304) | 2.85634131 |
| 27 | Leukodystrophy (HP:0002415) | 2.83330931 |
| 28 | Pheochromocytoma (HP:0002666) | 2.78025663 |
| 29 | Ankle clonus (HP:0011448) | 2.77103374 |
| 30 | Intention tremor (HP:0002080) | 2.75297515 |
| 31 | Abnormal auditory evoked potentials (HP:0006958) | 2.73233220 |
| 32 | Drooling (HP:0002307) | 2.70573373 |
| 33 | Cerebral hypomyelination (HP:0006808) | 2.67012410 |
| 34 | Myelomeningocele (HP:0002475) | 2.65883335 |
| 35 | Retinal dysplasia (HP:0007973) | 2.63475296 |
| 36 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.55759715 |
| 37 | Bifid tongue (HP:0010297) | 2.54661142 |
| 38 | Autoamputation (HP:0001218) | 2.52195941 |
| 39 | Dysmetria (HP:0001310) | 2.51655590 |
| 40 | Abnormal lung lobation (HP:0002101) | 2.49227626 |
| 41 | Volvulus (HP:0002580) | 2.48552956 |
| 42 | Stridor (HP:0010307) | 2.47686298 |
| 43 | Partial agenesis of the corpus callosum (HP:0001338) | 2.45231142 |
| 44 | Scanning speech (HP:0002168) | 2.43704595 |
| 45 | Renal hypoplasia (HP:0000089) | 2.39899164 |
| 46 | Hammertoe (HP:0001765) | 2.39448144 |
| 47 | Cerebral hemorrhage (HP:0001342) | 2.37193958 |
| 48 | Excessive salivation (HP:0003781) | 2.37099041 |
| 49 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.36515704 |
| 50 | Neuroendocrine neoplasm (HP:0100634) | 2.35391031 |
| 51 | Absent septum pellucidum (HP:0001331) | 2.31266307 |
| 52 | Slow saccadic eye movements (HP:0000514) | 2.30624511 |
| 53 | Spastic paraparesis (HP:0002313) | 2.29525283 |
| 54 | True hermaphroditism (HP:0010459) | 2.29506284 |
| 55 | Action tremor (HP:0002345) | 2.26116560 |
| 56 | Megalencephaly (HP:0001355) | 2.25298058 |
| 57 | Adrenal hypoplasia (HP:0000835) | 2.22915445 |
| 58 | Ulnar claw (HP:0001178) | 2.21826089 |
| 59 | Increased nuchal translucency (HP:0010880) | 2.21816017 |
| 60 | Alacrima (HP:0000522) | 2.20412856 |
| 61 | Lower limb muscle weakness (HP:0007340) | 2.19383230 |
| 62 | Colon cancer (HP:0003003) | 2.18776181 |
| 63 | Relative macrocephaly (HP:0004482) | 2.17757882 |
| 64 | Epidermoid cyst (HP:0200040) | 2.17278375 |
| 65 | Coronal craniosynostosis (HP:0004440) | 2.15199906 |
| 66 | Cutaneous finger syndactyly (HP:0010554) | 2.15108236 |
| 67 | Long clavicles (HP:0000890) | 2.14004887 |
| 68 | Foot dorsiflexor weakness (HP:0009027) | 2.13579998 |
| 69 | Lissencephaly (HP:0001339) | 2.12840390 |
| 70 | Hypophosphatemic rickets (HP:0004912) | 2.12648291 |
| 71 | Scrotal hypoplasia (HP:0000046) | 2.12045917 |
| 72 | Decreased motor nerve conduction velocity (HP:0003431) | 2.10979036 |
| 73 | Pancreatic fibrosis (HP:0100732) | 2.09648342 |
| 74 | Intestinal atresia (HP:0011100) | 2.09240652 |
| 75 | Abnormality of glycine metabolism (HP:0010895) | 2.08021725 |
| 76 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.08021725 |
| 77 | Urinary urgency (HP:0000012) | 2.07697926 |
| 78 | Broad alveolar ridges (HP:0000187) | 2.07479994 |
| 79 | Labial hypoplasia (HP:0000066) | 2.06921070 |
| 80 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06658283 |
| 81 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.05922190 |
| 82 | Abnormality of the metopic suture (HP:0005556) | 2.05851961 |
| 83 | Anomalous pulmonary venous return (HP:0010772) | 2.05811124 |
| 84 | Hypoplastic female external genitalia (HP:0012815) | 2.04702873 |
| 85 | Postaxial hand polydactyly (HP:0001162) | 2.03670317 |
| 86 | Intrahepatic cholestasis (HP:0001406) | 2.03016269 |
| 87 | Hemivertebrae (HP:0002937) | 2.02848138 |
| 88 | Steppage gait (HP:0003376) | 2.02264938 |
| 89 | Short 4th metacarpal (HP:0010044) | 1.99143120 |
| 90 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.99143120 |
| 91 | Increased circulating renin level (HP:0000848) | 1.98717889 |
| 92 | Abnormality of the septum pellucidum (HP:0007375) | 1.98214399 |
| 93 | Focal motor seizures (HP:0011153) | 1.98049138 |
| 94 | Postaxial foot polydactyly (HP:0001830) | 1.96975450 |
| 95 | Methylmalonic acidemia (HP:0002912) | 1.96857052 |
| 96 | Supernumerary spleens (HP:0009799) | 1.95958859 |
| 97 | Genital tract atresia (HP:0001827) | 1.94491971 |
| 98 | Pachygyria (HP:0001302) | 1.94039800 |
| 99 | Abnormality of the foot musculature (HP:0001436) | 1.93745324 |
| 100 | Medulloblastoma (HP:0002885) | 1.93605211 |
| 101 | High anterior hairline (HP:0009890) | 1.93568966 |
| 102 | Narrow forehead (HP:0000341) | 1.92051918 |
| 103 | Vitreoretinal degeneration (HP:0000655) | 1.91992521 |
| 104 | Gait imbalance (HP:0002141) | 1.91944085 |
| 105 | Thickened helices (HP:0000391) | 1.91300315 |
| 106 | Anteriorly placed anus (HP:0001545) | 1.90864106 |
| 107 | Clonus (HP:0002169) | 1.90028306 |
| 108 | Overlapping toe (HP:0001845) | 1.89643870 |
| 109 | Infantile muscular hypotonia (HP:0008947) | 1.89600662 |
| 110 | Clumsiness (HP:0002312) | 1.89476857 |
| 111 | Cupped ear (HP:0000378) | 1.89260387 |
| 112 | Cutaneous syndactyly (HP:0012725) | 1.88765183 |
| 113 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.88648048 |
| 114 | Hyperglycinuria (HP:0003108) | 1.87054143 |
| 115 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.86826009 |
| 116 | Aplasia of the phalanges of the hand (HP:0009802) | 1.86826009 |
| 117 | Aplasia involving bones of the extremities (HP:0009825) | 1.86826009 |
| 118 | Sclerocornea (HP:0000647) | 1.86126208 |
| 119 | Meningocele (HP:0002435) | 1.86072846 |
| 120 | Distal sensory impairment (HP:0002936) | 1.85695450 |
| 121 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.85601125 |
| 122 | Micropenis (HP:0000054) | 1.84622392 |
| 123 | Septate vagina (HP:0001153) | 1.84521906 |
| 124 | Abnormality of midbrain morphology (HP:0002418) | 1.83905252 |
| 125 | Molar tooth sign on MRI (HP:0002419) | 1.83905252 |
| 126 | Epiphyseal dysplasia (HP:0002656) | 1.83814109 |
| 127 | Split foot (HP:0001839) | 1.83678707 |
| 128 | Preaxial hand polydactyly (HP:0001177) | 1.82856286 |
| 129 | Hypomagnesemia (HP:0002917) | 1.82121027 |
| 130 | Septo-optic dysplasia (HP:0100842) | 1.81360182 |
| 131 | Morphological abnormality of the inner ear (HP:0011390) | 1.80423957 |
| 132 | Generalized hypotonia (HP:0001290) | 1.80181593 |
| 133 | Papillary thyroid carcinoma (HP:0002895) | 1.79924233 |
| 134 | Premature skin wrinkling (HP:0100678) | 1.79815503 |
| 135 | Optic nerve hypoplasia (HP:0000609) | 1.79478866 |
| 136 | Hemiparesis (HP:0001269) | 1.79277337 |
| 137 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.78683458 |
| 138 | Spastic tetraparesis (HP:0001285) | 1.78320795 |
| 139 | Abnormality of the vitreous humor (HP:0004327) | 1.76823445 |
| 140 | Abnormality of the pulmonary veins (HP:0011718) | 1.75195678 |
| 141 | Bicornuate uterus (HP:0000813) | 1.74476091 |
| 142 | Spastic paraplegia (HP:0001258) | 1.74153988 |
| 143 | Trigonocephaly (HP:0000243) | 1.74128107 |
| 144 | Oligodactyly (hands) (HP:0001180) | 1.74035373 |
| 145 | Oligodactyly (HP:0012165) | 1.72540973 |
| 146 | Dandy-Walker malformation (HP:0001305) | 1.72406291 |
| 147 | Absent eyebrow (HP:0002223) | 1.72325312 |
| 148 | Polyphagia (HP:0002591) | 1.72039769 |
| 149 | Anophthalmia (HP:0000528) | 1.70751458 |
| 150 | Pancreatic cysts (HP:0001737) | 1.70274667 |
| 151 | Gastrointestinal atresia (HP:0002589) | 1.70111433 |
| 152 | Glioma (HP:0009733) | 1.69979949 |
| 153 | Broad foot (HP:0001769) | 1.69870284 |
| 154 | Hypoplastic labia majora (HP:0000059) | 1.69193194 |
| 155 | Esophageal atresia (HP:0002032) | 1.69051140 |
| 156 | Specific learning disability (HP:0001328) | 1.68965871 |
| 157 | Congenital primary aphakia (HP:0007707) | 1.67689345 |
| 158 | Nephronophthisis (HP:0000090) | 1.67636732 |
| 159 | Nephrogenic diabetes insipidus (HP:0009806) | 1.67323813 |
| 160 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.67239525 |
| 161 | Short tibia (HP:0005736) | 1.67131891 |
| 162 | Hypoplasia of the iris (HP:0007676) | 1.67096100 |
| 163 | Urinary incontinence (HP:0000020) | 1.66856865 |
| 164 | Acute necrotizing encephalopathy (HP:0006965) | 1.66759650 |
| 165 | Synostosis involving the elbow (HP:0003938) | 1.66418780 |
| 166 | Humeroradial synostosis (HP:0003041) | 1.66418780 |
| 167 | Morphological abnormality of the middle ear (HP:0008609) | 1.66351694 |
| 168 | Abnormality of the diencephalon (HP:0010662) | 1.66078886 |
| 169 | Bifid scrotum (HP:0000048) | 1.64009350 |
| 170 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.64006515 |
| 171 | Hypoplastic left heart (HP:0004383) | 1.63548383 |
| 172 | Vaginal atresia (HP:0000148) | 1.63469862 |
| 173 | Decreased lacrimation (HP:0000633) | 1.63389315 |
| 174 | Paraplegia (HP:0010550) | 1.62991278 |
| 175 | Acute encephalopathy (HP:0006846) | 1.62248713 |
| 176 | Hepatosplenomegaly (HP:0001433) | 1.61952817 |
| 177 | Limb dystonia (HP:0002451) | 1.61859054 |
| 178 | Barrel-shaped chest (HP:0001552) | 1.61543696 |
| 179 | Neoplasm of the oral cavity (HP:0100649) | 1.61004808 |
| 180 | Abnormality of the lower motor neuron (HP:0002366) | 1.59759841 |
| 181 | Poor suck (HP:0002033) | 1.59457577 |
| 182 | Preaxial foot polydactyly (HP:0001841) | 1.59391572 |
| 183 | Medial flaring of the eyebrow (HP:0010747) | 1.59147438 |
| 184 | Anencephaly (HP:0002323) | 1.59123337 |
| 185 | Chronic hepatic failure (HP:0100626) | 1.58186769 |
| 186 | Microglossia (HP:0000171) | 1.58068921 |
| 187 | Impulsivity (HP:0100710) | 1.57915321 |
| 188 | Spastic diplegia (HP:0001264) | 1.57236578 |
| 189 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.56332893 |
| 190 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.55901574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.80616659 |
| 2 | OXSR1 | 3.87143431 |
| 3 | EPHB1 | 3.61596150 |
| 4 | BCR | 3.27992241 |
| 5 | WNK4 | 2.65735479 |
| 6 | PBK | 2.57223282 |
| 7 | MARK1 | 2.53276246 |
| 8 | LIMK1 | 2.47340239 |
| 9 | PKN1 | 2.45789181 |
| 10 | MKNK2 | 2.38491081 |
| 11 | MAPKAPK5 | 2.30410806 |
| 12 | TRIM28 | 2.23973508 |
| 13 | UHMK1 | 2.05695404 |
| 14 | TSSK6 | 2.01839132 |
| 15 | FGFR2 | 1.98380890 |
| 16 | MET | 1.96255678 |
| 17 | CSNK1G3 | 1.95585770 |
| 18 | WEE1 | 1.92473131 |
| 19 | CSNK1A1L | 1.78935247 |
| 20 | NTRK1 | 1.77350869 |
| 21 | DYRK2 | 1.77318574 |
| 22 | CASK | 1.74550251 |
| 23 | PNCK | 1.72076183 |
| 24 | TNIK | 1.71880193 |
| 25 | ERBB3 | 1.71701533 |
| 26 | SRPK1 | 1.71200030 |
| 27 | TESK2 | 1.70266759 |
| 28 | CDK19 | 1.59352970 |
| 29 | NEK1 | 1.58864085 |
| 30 | WNK1 | 1.57451174 |
| 31 | MST4 | 1.56157028 |
| 32 | CSNK1G2 | 1.55431891 |
| 33 | PLK4 | 1.49236244 |
| 34 | CSNK1G1 | 1.48596638 |
| 35 | EPHA3 | 1.47996109 |
| 36 | SGK223 | 1.44226737 |
| 37 | SGK494 | 1.44226737 |
| 38 | FGR | 1.40368427 |
| 39 | ROCK2 | 1.39544052 |
| 40 | TYRO3 | 1.39416744 |
| 41 | CDC7 | 1.38989163 |
| 42 | PAK6 | 1.35890083 |
| 43 | PLK3 | 1.35610058 |
| 44 | NUAK1 | 1.34756647 |
| 45 | ERBB4 | 1.26952166 |
| 46 | PAK3 | 1.22619362 |
| 47 | CAMK2B | 1.20912564 |
| 48 | MAPK13 | 1.19416074 |
| 49 | YES1 | 1.13200150 |
| 50 | TTK | 1.12857071 |
| 51 | NTRK2 | 1.12779478 |
| 52 | EPHA4 | 1.12580886 |
| 53 | PRKD3 | 1.12229613 |
| 54 | ICK | 1.08246338 |
| 55 | LATS1 | 1.07027755 |
| 56 | NEK6 | 1.06649645 |
| 57 | CLK1 | 1.05100693 |
| 58 | BRD4 | 1.04753790 |
| 59 | CDK14 | 1.01389727 |
| 60 | BMPR1B | 0.98142822 |
| 61 | DYRK3 | 0.97804180 |
| 62 | PRPF4B | 0.96661716 |
| 63 | CAMK2D | 0.93821958 |
| 64 | EIF2AK3 | 0.90558645 |
| 65 | PLK2 | 0.89660039 |
| 66 | CDK5 | 0.88722895 |
| 67 | KSR2 | 0.88049457 |
| 68 | PHKG1 | 0.87570554 |
| 69 | PHKG2 | 0.87570554 |
| 70 | BRSK2 | 0.86088766 |
| 71 | MAP4K2 | 0.84915160 |
| 72 | CDK15 | 0.84241081 |
| 73 | CDK18 | 0.83599357 |
| 74 | NEK2 | 0.82382448 |
| 75 | CAMK2A | 0.82333007 |
| 76 | LATS2 | 0.82262464 |
| 77 | RPS6KA4 | 0.80498108 |
| 78 | PLK1 | 0.77683358 |
| 79 | EIF2AK1 | 0.75736134 |
| 80 | MAP3K10 | 0.75212959 |
| 81 | MINK1 | 0.73708917 |
| 82 | CDK11A | 0.73708361 |
| 83 | MAP3K9 | 0.72871763 |
| 84 | MAP3K4 | 0.70586030 |
| 85 | CAMK2G | 0.70118851 |
| 86 | ARAF | 0.69380767 |
| 87 | MARK2 | 0.68713835 |
| 88 | TAF1 | 0.66928833 |
| 89 | PRKCE | 0.65841295 |
| 90 | PINK1 | 0.64466098 |
| 91 | PRKCQ | 0.64285693 |
| 92 | ATM | 0.63071221 |
| 93 | BUB1 | 0.61400038 |
| 94 | IRAK2 | 0.61019779 |
| 95 | ATR | 0.60107851 |
| 96 | WNK3 | 0.60068469 |
| 97 | FGFR1 | 0.59908125 |
| 98 | ZAK | 0.59425500 |
| 99 | GSK3A | 0.55439899 |
| 100 | PRKD1 | 0.55431361 |
| 101 | MKNK1 | 0.55260966 |
| 102 | MAP3K2 | 0.54927659 |
| 103 | DYRK1A | 0.54259737 |
| 104 | CDK3 | 0.54239808 |
| 105 | EIF2AK2 | 0.53244111 |
| 106 | DDR2 | 0.53181178 |
| 107 | TGFBR1 | 0.52545477 |
| 108 | CAMK1D | 0.52315725 |
| 109 | FER | 0.52125169 |
| 110 | CSNK1D | 0.51932552 |
| 111 | VRK1 | 0.50726955 |
| 112 | KSR1 | 0.50487755 |
| 113 | SIK3 | 0.48753503 |
| 114 | STK3 | 0.48243480 |
| 115 | CCNB1 | 0.47287054 |
| 116 | CAMK1G | 0.46769019 |
| 117 | CHEK2 | 0.46732448 |
| 118 | FYN | 0.46385452 |
| 119 | PRKDC | 0.45545713 |
| 120 | ROCK1 | 0.44548515 |
| 121 | MAPK15 | 0.44230748 |
| 122 | PRKG1 | 0.43636869 |
| 123 | CHEK1 | 0.42711803 |
| 124 | MAP2K2 | 0.41263222 |
| 125 | * CDK1 | 0.41167809 |
| 126 | MAP2K4 | 0.40923790 |
| 127 | NTRK3 | 0.39237033 |
| 128 | PRKACB | 0.39173240 |
| 129 | PDPK1 | 0.38770957 |
| 130 | ACVR1B | 0.38696715 |
| 131 | SGK2 | 0.38091459 |
| 132 | BRSK1 | 0.35733898 |
| 133 | RET | 0.35561218 |
| 134 | CSNK1A1 | 0.35168671 |
| 135 | EPHB2 | 0.35000096 |
| 136 | ADRBK1 | 0.33167131 |
| 137 | CSNK1E | 0.32463512 |
| 138 | MAP2K7 | 0.32154005 |
| 139 | PDGFRB | 0.30748602 |
| 140 | PRKACA | 0.30639696 |
| 141 | GRK5 | 0.30531402 |
| 142 | RPS6KA5 | 0.29194261 |
| 143 | ERBB2 | 0.28777258 |
| 144 | LMTK2 | 0.27667764 |
| 145 | DAPK2 | 0.25726318 |
| 146 | PAK1 | 0.25456899 |
| 147 | PIK3CA | 0.25376188 |
| 148 | PRKCZ | 0.25215713 |
| 149 | STK11 | 0.24944051 |
| 150 | GRK7 | 0.23867063 |
| 151 | PRKCG | 0.23739676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 6.84630647 |
| 2 | * Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 6.35592176 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.35194263 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.65984023 |
| 5 | * Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.14358710 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.48761520 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.87980808 |
| 8 | * Butanoate metabolism_Homo sapiens_hsa00650 | 1.74462229 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73294840 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.70666145 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65686856 |
| 12 | Axon guidance_Homo sapiens_hsa04360 | 1.64800057 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58232284 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.57518452 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52298875 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.42058017 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39962324 |
| 18 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.36813472 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.27217771 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.26296240 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.23882344 |
| 22 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.21361278 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.17291801 |
| 24 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.16105189 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.15508881 |
| 26 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11358981 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.10223387 |
| 28 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.09043686 |
| 29 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.08011417 |
| 30 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06833301 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.06611900 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05446105 |
| 33 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.04982057 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.04174474 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.02756085 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.01721835 |
| 37 | Cell cycle_Homo sapiens_hsa04110 | 1.00252626 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 0.99262965 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99162525 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99161622 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97287260 |
| 42 | Mismatch repair_Homo sapiens_hsa03430 | 0.96136565 |
| 43 | RNA transport_Homo sapiens_hsa03013 | 0.94577439 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92306394 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91706878 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91666202 |
| 47 | Protein export_Homo sapiens_hsa03060 | 0.89291079 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 0.88914762 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87804217 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86477322 |
| 51 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.86305807 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 0.85229688 |
| 53 | RNA degradation_Homo sapiens_hsa03018 | 0.83775841 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83273621 |
| 55 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.82730347 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82666267 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81441751 |
| 58 | Long-term depression_Homo sapiens_hsa04730 | 0.80522149 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80279028 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79394840 |
| 61 | Tight junction_Homo sapiens_hsa04530 | 0.78895819 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78801387 |
| 63 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70918751 |
| 64 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.70772999 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70709403 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70016750 |
| 67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67740464 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67699031 |
| 69 | DNA replication_Homo sapiens_hsa03030 | 0.67233000 |
| 70 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67199688 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.66963317 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66543469 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66181975 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65599750 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.65377712 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64161228 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63734834 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62377666 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.61997005 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60335584 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59468513 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59453791 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58518822 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58481881 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58063322 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.57546909 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57036713 |
| 88 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55962532 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55818542 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54519985 |
| 91 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52801074 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52622190 |
| 93 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.52184787 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51267890 |
| 95 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51203921 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51010767 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50565123 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.50329765 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49480491 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48825915 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48739837 |
| 102 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47793396 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46770875 |
| 104 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46747757 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46081252 |
| 106 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45609835 |
| 107 | Taste transduction_Homo sapiens_hsa04742 | 0.44917777 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44415774 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.44168448 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42819722 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41943208 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41730839 |
| 113 | Alcoholism_Homo sapiens_hsa05034 | 0.41256135 |
| 114 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.41055975 |
| 115 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.40864315 |
| 116 | Nicotine addiction_Homo sapiens_hsa05033 | 0.40297570 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40243085 |
| 118 | Gap junction_Homo sapiens_hsa04540 | 0.38807128 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.38804512 |
| 120 | Base excision repair_Homo sapiens_hsa03410 | 0.38794766 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38082134 |
| 122 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37247660 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37111961 |
| 124 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36709559 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36699490 |
| 126 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35875634 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35761477 |
| 128 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.35099826 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.34075554 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.33698240 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31667252 |
| 132 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29749982 |
| 133 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28644591 |
| 134 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.28623149 |
| 135 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28178039 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.27710922 |
| 137 | Mineral absorption_Homo sapiens_hsa04978 | 0.26744322 |
| 138 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.26021909 |
| 139 | Salivary secretion_Homo sapiens_hsa04970 | 0.24847619 |
| 140 | Phototransduction_Homo sapiens_hsa04744 | 0.24216693 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24026280 |
| 142 | Renin secretion_Homo sapiens_hsa04924 | 0.23432615 |
| 143 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.20287712 |
| 144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.19640191 |
| 145 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19046274 |
| 146 | Melanogenesis_Homo sapiens_hsa04916 | 0.18898811 |

